VIFOR PHARMA

HQ: Glattbrugg (near Zürich), Switzerland

Founded in: 1944

Web: www.viforpharma.ch/en

Vifor Pharma Switzerland is a fully integrated pharmaceutical company within the Vifor Pharma Group primarily. It concentrates on the widespread condition of iron deficiency and specialty medications in a number of therapeutic areas.

The company’s main areas of business are:

• Regulatory affairs
• Early market access programmes
• Pricing and reimbursement
• Launch readiness
• Partner management
• Individual product support by specialised resources: marketing, medical liaison, key account management, sales force and distribution
• Expertise in many therapeutic areas and with leading products (i.e. originals, generics, drug device combinations, orphan drugs).

Therapeutic Areas

• Iron deficiency
• Renal insufficiency and its consequences
• Depression
• Mild cognitive impairment
• Menopause
• Urinary tract infections
• Respiratory tract infections
• Cystic fibrosis
• Alpha-1 antitrypsin deficiency
• Crohn’s disease, ulcerative colitis
• Oncology and supportive care

Target groups

• Retail and hospital
• General practitioners
• Consultants and speicialists
• Cystic fibrosis centres

Business Units

• Cardiology, Nephrology & Oncology, Primary Care, Gynaecology & Gastroenterology (All based in Villars-sur-Glâne, Switzerland)

Key data

• Net sales: CHF 123.7m (2017)
• Employees: 94